Our organization

About Clincol

A 501(c)(3) nonprofit built on the belief that every person deserves to understand what they’re putting in their body — free from jargon, free from paywalls, and free from pharmaceutical marketing.

Our mission

Information asymmetry in drug safety is a public health problem

The FDA generates millions of adverse event reports. Pharmaceutical companies produce dense, 80-page prescribing information documents. None of it is written for the person actually taking the medication.

Clincol exists to close that gap. We take official federal data — from FDA, SAMHSA, NIH, and CDC — and translate it into plain language for patients, students, clinicians, and advocates.

We are structurally funded by Arbitrant, our for-profit partner, which covers all hosting and AI costs in exchange for aggregated public search data. This is not charity — it’s a designed economic model.

501(c)(3)
Federal nonprofit status
$0
Cost to users, forever
0
Advertisements, ever
8
Drugs fully profiled at launch
100%
FDA/federal data sourced
Grant funding strategy

How Clincol stays free forever

A diversified nonprofit funding model: federal health agency grants, private foundations, and Arbitrant’s structural infrastructure contribution.

SAMHSA
Strategic Prevention Framework Partnership
Funds community digital platforms for substance abuse prevention education. Clincol’s addiction awareness content is a direct match.
$500K–$1M
5-year cycle · Renewable
NIH / NIDA
Science Education Drug Abuse Partnership
Supports science-based drug education for the general public. Funds the plain-language translation mission at the core of the Drug Atlas.
$250K–$750K
R01 renewable · 3-year initial
FDA
Patient Safety & Drug Education Initiative
For nonprofits improving patient access to comprehensible drug safety information. Directly addresses FDA’s stated label comprehension problem.
$100K–$400K
Annual · Multi-year track
Robert Wood Johnson Foundation
Health Equity Digital Access
RWJF funds digital health tools serving under-resourced populations. Clincol’s free, zero-paywall design aligns with their equity priorities.
$200K–$500K
2-year project grant
Arnold Ventures
Drug Pricing & Transparency
Funds pharmaceutical transparency projects. The Drug Atlas and Pipeline Watch align with their market information asymmetry focus.
$150K–$600K
Project-based · Competitive
Arbitrant (Infrastructure)
Shared Infrastructure Contribution
Arbitrant covers 100% of hosting, database, and AI compute costs as a structural cross-subsidy — built into their operating budget by design.
~$18K/yr
Neon + Netlify + Claude API · Ongoing
Arbitrant connection

One infrastructure. Two missions.

Arbitrant sells clinical intelligence commercially to biotech VCs, BD teams, and founders. Clincol gives the same underlying data away — translated for patients and students. Same database, same AI, same stack. Different purpose.

Visit Arbitrant.com →
📊
Arbitrant ingests FDA + clinical trial data
ClinicalTrials.gov, FAERS, DailyMed — pulled once, stored in shared Neon Postgres, queried by both platforms.
💰
Pro subscriptions fund Clincol’s AI compute
Stripe revenue covers Claude API costs. Clincol’s translation layer is inherited at zero marginal cost.
🌿
Clincol serves the public layer
Same data, plain-language framing, four audience modes. Supabase row-level security keeps commercial and public reads separated.
🔄
Clincol search volume feeds Arbitrant gap signals
High public search + low trial density = elevated Arbitrant gap score. The nonprofit generates real commercial signal.
Get in touch

Contact us

For press, partnership, grant, or general inquiries — we’re a small team and respond within 48 hours.

General inquiries
hello@clincol.org
Questions, feedback, or general information
Press & media
press@clincol.org
Media requests, interviews, data access
Grant & partnerships
grants@clincol.org
Funding opportunities and institutional partnerships
Crisis support (not us)
1-800-662-4357
SAMHSA — free, confidential, 24/7